Terms: = Prostate cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Prognosis
4 results:
1. Coronary artery bypass grafting in patients with concomitant solid tumours: early and long-term results.
Garatti A; D'Ovidio M; Saitto G; Daprati A; Canziani A; Mossuto E; D'Oria V; Scarpanti M; De Vincentiis C; Parolari A; Menicanti L
Eur J Cardiothorac Surg; 2020 Sep; 58(3):528-536. PubMed ID: 32474575
[TBL] [Abstract] [Full Text] [Related]
2. Role of merlin/nf2 inactivation in tumor biology.
Petrilli AM; Fernández-Valle C
Oncogene; 2016 Feb; 35(5):537-48. PubMed ID: 25893302
[TBL] [Abstract] [Full Text] [Related]
3. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.
Ozkan EE
Mol Cell Endocrinol; 2011 Sep; 344(1-2):1-24. PubMed ID: 21782884
[TBL] [Abstract] [Full Text] [Related]
4. Clinical implications of the influence of Ehm2 on the aggressiveness of breast cancer cells through regulation of matrix metalloproteinase-9 expression.
Yu H; Ye L; Mansel RE; Zhang Y; Jiang WG
Mol Cancer Res; 2010 Nov; 8(11):1501-12. PubMed ID: 21047774
[TBL] [Abstract] [Full Text] [Related]
